# Halobetasol Propionate

NDC: 21922-108
Generic name: Halobetasol Propionate
Labeler / Manufacturer: Encube Ethicals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20260701

FDA application: ANDA209978

## Active ingredients

- HALOBETASOL PROPIONATE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"21922-108"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=21922-108
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4f03a79-3d5e-4a39-8ab0-8ebd3d804e39